Instead of directly targeting VEGF, an indirect approach was recommended for materializing dual-modulation of the tumor vascular system and TME through VEGF/HIF-1 mediated by the PI3K/Akt/mTOR cascade and preventing drug resistance (Fokas et al., 2012). The gene discussed is VEGFA; the disease is neoplasm.